Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mai-Chi N. Tran, Ravina Kullar & Ellie J. C. Goldstein. (2019) Investigational drug therapies currently in early-stage clinical development for
the treatment of clostridioides (clostridium) difficile infection. Expert Opinion on Investigational Drugs 28:4, pages 323-335.
Read now
Read now
Olapeju Bolarinwa & Jianfeng Cai. (2018) Developments with investigating descriptors for antimicrobial AApeptides and their derivatives. Expert Opinion on Drug Discovery 13:8, pages 727-739.
Read now
Read now
Articles from other publishers (20)
Ahmed M. Kamal El-sagheir, Ireny Abdelmesseh Nekhala, Mohammed K. Abd El-Gaber, Ahmed S. Aboraia, Jonatan Persson, Ann-Britt Schäfer, Michaela Wenzel & Farghaly A. Omar. (2023) Design, Synthesis, Molecular Modeling, Biological Activity, and Mechanism of Action of Novel Amino Acid Derivatives of Norfloxacin. ACS Omega 8:45, pages 43271-43284.
Crossref
Crossref
Shuo Yuan, Dan-Dan Shen, Yi-Ru Bai, Miao Zhang, Tian Zhou, Chong Sun, Li Zhou, Sai-Qi Wang & Hong-Min Liu. (2023) Oxazolidinone: A promising scaffold for the development of antibacterial drugs. European Journal of Medicinal Chemistry 250, pages 115239.
Crossref
Crossref
Ioana-Andreea Lungu, Octavia-Laura Moldovan, Victoria Biriș & Aura Rusu. (2022) Fluoroquinolones Hybrid Molecules as Promising Antibacterial Agents in the Fight against Antibacterial Resistance. Pharmaceutics 14:8, pages 1749.
Crossref
Crossref
Jacob McPherson, Chenlin Hu, Khurshida Begum, Weiqun Wang, Chris Lancaster, Anne J. Gonzales-Luna, Caroline Loveall, Michael H. Silverman, M. Jahangir Alam & Kevin W. Garey. (2022) Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection. Antimicrobial Agents and Chemotherapy 66:8.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
343
374
.
BG Andryukov. (2021) Nanotechnologies in the Light of Modern Antibacterial Strategies: A Review. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT, pages 67-77.
Crossref
Crossref
Cody R. Fisher, Suzannah M. Schmidt-Malan, Zhenkun Ma, Ying Yuan, Shijie He & Robin Patel. (2020) In vitro activity of TNP-2092 against periprosthetic joint infection–associated staphylococci. Diagnostic Microbiology and Infectious Disease 97:3, pages 115040.
Crossref
Crossref
Declan Alan Gray & Michaela Wenzel. (2020) Multitarget Approaches against Multiresistant Superbugs. ACS Infectious Diseases 6:6, pages 1346-1365.
Crossref
Crossref
Zifang Shang, Siew Yin Chan, Qing Song, Peng Li & Wei Huang. (2020) The Strategies of Pathogen-Oriented Therapy on Circumventing Antimicrobial Resistance. Research 2020.
Crossref
Crossref
Prashant Dhiman, Nidhi Arora, Punniyakoti Veeraveedu Thanikachalam & Vikramdeep Monga. (2019) Recent advances in the synthetic and medicinal perspective of quinolones: A review. Bioorganic Chemistry 92, pages 103291.
Crossref
Crossref
Lyudmila Boyanova, Rumyana Markovska & Ivan Mitov. (2019) Multidrug resistance in anaerobes. Future Microbiology 14:12, pages 1055-1064.
Crossref
Crossref
Andrew J. Tague, Papanin Putsathit, Melanie L. Hutton, Katherine A. Hammer, Steven M. Wales, Daniel R. Knight, Thomas V. Riley, Dena Lyras, Paul A. Keller & Stephen G. Pyne. (2019) Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model. European Journal of Medicinal Chemistry 170, pages 203-224.
Crossref
Crossref
Ken F Blount, William D Shannon, Elena Deych & Courtney Jones. (2019) Restoration of Bacterial Microbiome Composition and Diversity Among Treatment Responders in a Phase 2 Trial of RBX2660: An Investigational Microbiome Restoration Therapeutic. Open Forum Infectious Diseases 6:4.
Crossref
Crossref
Fanny Mathias, Christophe Curti, Marc Montana, Charléric Bornet & Patrice Vanelle. (2018) Management of adult Clostridium difficile digestive contaminations: a literature review. European Journal of Clinical Microbiology & Infectious Diseases 38:2, pages 209-231.
Crossref
Crossref
Antonio Palumbo Piccionello, Ivana Pibiri, Silvestre Buscemi & Andrea Pace. 2019. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals. Fluorine in Life Sciences: Pharmaceuticals, Medicinal Diagnostics, and Agrochemicals
213
239
.
Hemant Goyal, Abhilash Perisetti, M. Rubayat Rehman & Umesh Singla. (2018) New and emerging therapies in treatment of Clostridium difficile infection. European Journal of Gastroenterology & Hepatology 30:6, pages 589-597.
Crossref
Crossref
Nicola Petrosillo, Guido Granata & Maria Adriana Cataldo. (2018) Novel Antimicrobials for the Treatment of Clostridium difficile Infection. Frontiers in Medicine 5.
Crossref
Crossref
Ronald Domalaon, Temilolu Idowu, George G. Zhanel & Frank Schweizer. (2018) Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?. Clinical Microbiology Reviews 31:2.
Crossref
Crossref
Ronald Domalaon, Xuan Yang, Yinfeng Lyu, George G. Zhanel & Frank Schweizer. (2017)
Polymyxin B
3
–Tobramycin Hybrids with
Pseudomonas aeruginosa
-Selective Antibacterial Activity and Strong Potentiation of Rifampicin, Minocycline, and Vancomycin
. ACS Infectious Diseases 3:12, pages 941-954.
Crossref
Crossref
Natalia Molchanova, Paul Hansen & Henrik Franzyk. (2017) Advances in Development of Antimicrobial Peptidomimetics as Potential Drugs. Molecules 22:9, pages 1430.
Crossref
Crossref